Yoshihiro Uto is a Full Professor at Graduate School of Technology, Industrial and Social Sciences, Tokushima University. He completed his Ph.D. at the Kyushu Institute of Technology Graduate School of Information Engineering. Before his current appointment, he was a Research Fellow of the Japan Society for the Promotion of Science. He is engaged in research in analytical chemistry, organic chemistry, and medicinal chemistry, and he is developing a multifunctional radiosensitizer that targets cancer survival strategies. He also advocates isoprenomics, which refers to drug discovery research using isoprenoids such as artepillin C, and has recently been actively engaged in drug discovery research using in vivo activity as an indicator using embryonated chicken eggs. He has also developed immunotheraputics using serum GcMAF, which uses human serum glycoproteins as a lead and can treat cancer, AIDS, and infectious diseases, at a clinic with which he is conducting joint research.
Yoshihiro Uto is a Full Professor at Graduate School of Technology, Industrial and Social Sciences, Tokushima University. He completed his Ph.D. at the Kyushu Institute of Technology Graduate School of Information Engineering. Before his current appointment, he was a Research Fellow of the Japan Society for the Promotion of Science. He is engaged in research in analytical chemistry, organic chemistry, and medicinal chemistry, and he is developing a multifunctional radiosensitizer that targets cancer survival strategies. He also advocates isoprenomics, which refers to drug discovery research using isoprenoids such as artepillin C, and has recently been actively engaged in drug discovery research using in vivo activity as an indicator using embryonated chicken eggs. He has also developed immunotheraputics using serum GcMAF, which uses human serum glycoproteins as a lead and can treat cancer, AIDS, and infectious diseases, at a clinic with which he is conducting joint research.